Mental Health

The use of psilocybin and psychedelic therapy can be a helpful tool for individuals with AUD and could have a positive outcome that can result in self compassion.

The benefits of the survey can stretch beyond assessing the parental acceptability of mental health screenings in children and can suggest areas of optimization in providing these screenings more widely and effectively in the future.

Evidence shows vitamin D deficiency is linked to abnormal dopamine signaling disorders in neurodevelopment, including schizophrenia.

Employees who did frequently use AI systems were more than likely to offer help to fellow employees, though it could have been a response to their loneliness.

Several workplace risk factors, including safety concerns going unaddressed, predicted suicidal thoughts.

Depression can affect the trajectory of treatment and associated outcomes.

Pharmacogenomics is gaining support in mental health and polypharmacy, where the data make a strong case for improvements in clinical and economic outcomes.

Providing this treatment for patients with cancer may be a smoother transition for oncology professionals than they might expect.

The ease of administration with new agents for schizophrenia via an injection is advantageous because this patient population is commonly agitated and difficult to administer oral medications to.

The study will assess the use of the drug to treat impaired social motivation, or asociality, which is a difficult-to-treat symptom of schizophrenia that can cause significant functional impairment.

The estimated cost burden of schizophrenia is more than $150 billion, consisting of direct treatment cost and lost productivity.

Pharmacogenomic testing in combination with therapeutic drug monitoring can be a cost effective and efficient way to advance psychiatric drug therapy.

Untreated hearing loss can affect communication, loneliness, and lead to severe illness, such as dementia.

Patients with depression require long-term treatment and supportive care, either with medications or non-pharmaceutical options.

The steroid could be more effective for veterans with post-traumatic stress disorder who do not have a history of traumatic brain injury.

Anxiety disorders create social and economic burdens as the availability of effective anxiolytic treatments are low.

The drug is available in 2 formulations, including a weekly injection with a lower dose than previously available as well as a monthly injection.

Common chronic pain conditions included in the analysis were fibromyalgia, neuropathic pain, and musculoskeletal pain.

Health care professionals should educate patients that it is possible to effectively manage pain without opioids.

Teva is unable to meet demand for dextroamphetamine/amphetamine, and other companies struggle to keep up.

Routinely celebrating their work contributions and dedication adds value to your organization.

There are common symptoms experienced in the workplace that may be linked to hormones instead of stress.

Mental health interventions are a critical part of the global response to HIV, with multiple potential roles for psychiatrists and other mental health professionals.

The flexible 1- and 2-month dosing intervals of risperidone could help address adherence challenges common with schizophrenia treatments.

Investigators suggest that a checklist completed by physicians and family members of individuals with severe acute brain injury may improve management needs.

The formulation in 960 mg and 720 mg prefilled syringes delivers sustained plasma concentrations comparable to those demonstrated in studies with Abilify Maintena.

Pharmacists were asked about their levels of burnout, drivers and symptoms of this burnout, and what steps their workplaces had taken to improve the issue.

As psychedelic medicine comes further into cancer care, pharmacists will be an important part of the interdisciplinary team in screening and evaluating patients for suitability for psychedelic medicine.

Poor sleep efficiency may contribute to vascular dysfunction with increasing exposure to adverse childhood experiences.

Host Christina Madison, PharmD, BCACP, AAHIVP, sat down with Jeffrey Bratberg, PharmD, FAPhA, a clinical professor in the college of pharmacy at the University of Rhode Island